Wyeth stockholders approve acquisition by Pfizer
MADISON, N.J. Wyeth stockholders have approved the company’s acquisition by Pfizer, Wyeth announced Monday.
The drug maker said more than 98% of shares voted in favor of the merger, which the company’s board approved earlier this year amid a wave of large-scale pharmaceutical company mergers.
“The merger is in the best interests of our company and our stockholders,” Wyeth chairman, president and CEO Bernard Poussot said in a statement. “Combined with Pfizer, we see opportunities for increased scale where needed and resources to become the world’s first premier biopharmaceutical company and an industry leader in human, consumer and animal health care.”
Two PureSport athlete spokespersons awarded at 2009 ESPY Awards
AUSTIN, Texas Two PureSport athlete spokespersons — swimmer Michael Phelps and gymnast Nastia Liukin — were awarded the 2009 ESPY for Best Male and Best Female Athlete, respectively, the company announced Friday.
“There’s a reason [Phelps] and [Liukin] chose to train for the Beijing Olympics with PureSport and there’s a reason why they had the best athletic performances in the world last year,” stated Michael Humphrey, PureSport CEO. “PureSport is the most scientifically-sound and effective sports drink in the world and it helps athletes get more out of their performances.”“PureSport played an integral role in my success in Beijing,” Phelps said, who helped develop the drink in 2007 with John Ivy, chair of the Department of Kinesiology and Health Education at the University of Texas at Austin. “PureSport’s recovery drink helped me race at peak levels day after day at the Olympics. It makes a huge difference in terms of reducing muscle tissue damage and soreness and promoting muscle repair.”
PureSport is formulated with a 2.67-to-1 carbohydrate-to-protein ratio, which is an ideal ratio for muscle performance, Humphrey said.
The 2009 ESPY Awards will air on ESPN on July 19.
WHO to stop disclosing global tables of confirmed H1N1 cases; will continue to document pandemic
GENEVA The World Health Organization announced on Thursday it would no longer provide the global tables showing the numbers of confirmed cases for all countries. However, as part of continued efforts to document the global spread of the H1N1 pandemic, regular updates will be provided describing the situation in the newly affected countries.
“At this point, further spread of the pandemic, within affected countries and to new countries, is considered inevitable,” WHO stated. “The 2009 influenza pandemic has spread internationally with unprecedented speed. In past pandemics, influenza viruses have needed more than six months to spread as widely as the new H1N1 virus has spread in less than six weeks,” making it extremely difficult for countries to try and confirm novel H1N1 infections through laboratory testing.
The novel H1N1 pandemic has been characterized, to date, by the mildness of symptoms in the overwhelming majority of patients, who usually recover, even without medical treatment, within a week of the onset of symptoms, WHO stated. But countries still need to be on guard for signals indicating a more virulent, or more deadly strain, such as spikes in rates of absenteeism from schools or workplaces or a surge in emergency department visits.